background image

LIU Hui-rong, et al. Clinical Research of Irritable Bowel Syndrome Treated by Electroacupuncture on ST 25 
DOI: 10.1007/s11726-007-0091-8 

Copyright ©

 

2007 Shanghai Research Institute of Acupuncture and Meridian︱

     

91

      ●

 

Clinical Study 

Clinical Research of Irritable Bowel Syndrome Treated by 

Electroacupuncture on Tianshu(ST 25) 

 

LIU Hui-rong(刘慧荣)

 1, 2

, WU Huan-gan(吴焕淦)

 1

, WANG Xiao-long(王小龙)

 1

, ZUO Chuan-tao(左传涛)

 3

GUAN Yi-hui(管一辉)

3

, FANG Jian-qiao(方剑乔)

 4

 

1. Shanghai Research Institute of Acupuncture and Meridian, Shanghai, 200030, P. R. China 
2. Shanghai Research Center of Acupuncture and Meridian, Shanghai, 201203, P. R. China 
3. Huashan Hospital, Fudan University, Shanghai, 310053, P. R. China 
4. Zhejiang University of TCM, Hangzhou, 200030, P. R. China 

 
摘要  目的:对电针天枢穴治疗腹泻型肠易激综合征(D-IBS)的临床疗效进行综合评价,促
进电针天枢穴治疗腹泻型肠易激综合征的应用和推广。方法:以随机、对照、单盲的方
法,对就诊的

103 例符合纳入标准的D-IBS患者随机分为电针天枢穴组(n=53)和电针大横

穴组

(n=50)。两个疗程后进行疗效统计,两组之间综合疗效比较采用Radit分析。结果:

D-IBS的腹泻、腹痛、腹胀或腹部不适、肠鸣、排便急迫感、排便不尽感等症状的发生率
分别为

100%、89.3%、71.8%、74.8%、83.5%、78.6%等;  综合疗效分析,电针天枢穴

组显效

11 例,好转 34 例,无效 8 例,总有效 45 例,总有效率 84.9%;电针大横穴组显

4 例,好转 26 例,无效 20 例,总有效 30 例,总有效率 60.0%。两组疗效差异具有统

计意义

(P<0.05)。结论:电针天枢穴治疗D-IBS临床疗效优于电针大横穴。 

关键词:肠易激综合征;穴

,  天枢;电针 

Abstract  Objectives: By observing and evaluating the clinical curative effect systematically 
of electrical acupuncture (EA) on Tianshu (ST 25) on diarrhea-predominant irritable bowel 
syndrome (D-IBS), to make it benefit for the application and spread of EA on Tianshu (ST 25) 
on D-IBS.    Methods: 103 D-IBS matched the involved standards were allocated into treatment 
group (EA on ST 25, n=53) and control group (EA on Daheng, SP 15, n=50) in randomized, 
controlled and single-blind ways. Curative effect differences were analyzed by Ridit analysis. 
Results: The incidence of diarrhea, abdominal pain, abdominal distention or abdominal 
discomfort, borborygmus, defecation urgency and defecation incompletion feeling were 100%, 
89.3%, 71.8%, 74.8%, 83.5% and 78.6% respectively in D-IBS. Generally, after treatment, 11 
cases got excellent results, 34 cases improved and 8 failed in treatment group, totally effective 
rate was 84.9%; while in control group, 4 cases got excellent effects, 26 improved and 20 failed, 
totally the effective rate was 60.0%. Conclusion: Compared with control group, EA on Tianshu 
(ST 25) has a better curative effect on D-IBS. 

Key Words: Irritable Bowel Syndrome; Point, ST 25; Electroacupuncture 
CLC Number: R246.6 
Document Code: 
 

 

Foundation item: Supported by State Administration of TCM of 

the People's Republic of China(Proj. No. 03XDLZ26; Supported 
by Shanghai Leading Academic Discipline Project(Proj. No. 
T0302); Supported by Shanghai Commission of Science & 
Technology(Proj. No. 03DZ19554-5); The Leading Talents of 
Medical Science in Shanghai (Proj. No.LJ06019) 

Irritable bowel syndrome (IBS) is one of the most 

commonly intermittent or durative gastrointestinal 
disorders. Primary symptoms of IBS are chronic 
recurrent abdominal pain and alterations in bowel 
function. Such alterations can present as diarrhea or 
constipation, or alternating of the two. The key signs 
of IBS are located in colons but often involved a 
psychosomatic condition. With rapid rhythm of social 

background image

Journal of Acupuncture and Tuina Science, Volume 5, Number 2, 2007 April 

  92  

 

Copyright©2007 Shanghai Research Institute of Acupuncture and Meridian 

life, working stress, and life style changes, the 
prevalence of IBS is going up. The large-sample 
surgery in Europe and U.S.A.  in recent years 
showed the prevalence of IBS is up to 22%

[1]

 

While 

in China, one third of patients visiting gastrointestinal 
section belong to IBS, around 15% in all

[2]

.  

Until now, there is no specific drug that wores for 

all the patients. Many IBS patients accept a single 
remedy, and most remedies are symptom-oriented and 
some measures are not appropriate in terms of health 
economics criteria, leading to unsatisfactory 
therapeutic efficacy. Therefore, it is necessary to find 
a new remedy to cope with both criteria and 
effectiveness. Recently, reports at home and abroad 
have shown that acupuncture remedy has satisfactory 
therapeutic effects on IBS, previous studies of our 
research group, from aspects of clinic and mechanism, 
have indicated that acupuncture represents potentially 
valuable therapeutic remedy for treatment of IBS.

 [3-7] 

Our research aims to develop a multi-centre, 
single-blinded, randomized, controlled clinical trial, 
103 patients with diarrhea-predominant irritable 
bowel patterns have been screened and grouped. 
Efficacy for remedy of diarrhea-predominant IBS 
(D-D-IBS) by electric acupuncture (EA) on Tianshu 
(ST 25) has been evaluated objectively and 
systematically. The remedy based on Tianshu(ST 25) 
provides scientific foundation of clinic, and it is also 
inclined to promote popularity and utility for 
treatment of D-IBS by EA on Tianshu(ST 25).   

 

Clinical Data 

 

1. Diagnostic criteria 

As there is no special and objective or physical 

criteria for IBS, patients were required to have had 
symptoms that fulfilled the classification and 
diagnostic criteria of D-IBS from ROME II

[8] 

 for 

functional gastrointestinal disease. 

 

2. Inclusive criteria   

a. Diarrhea-predominant bowel pattern; 
b. Aged 18 years to 65; 
c. Not taking alosetron, Octreotide, herbs and other 

remedies to treat IBS at the same time;   

d. No severe disease of other organs, such as heart, 

brain, liver, kidney, and no psychotic diseases;   

e. Willing to join the trial and sign the infored 

consent.  

 
3. Exclusive criteria   

a. Organic bowel diseases; 
b. Women during pregnancy or lactation;   
c. Severe disease of other organs, such as heart, 

brain, liver, kidney, and no psychotic diseases. 

 
4. Ending and drop-out criteria 

According to the criteria to end and drop out partial 

included patients, and carefully record the cause of 
ending and dropping out, and its relationship with 
clinical research. ①failing to keep on the overall 
treatment period. ②failing to follow the trial design. 

presenting severe adverse effects. ④presenting 

complication or deterioration during the process of 
treatment. 

 
5. Baseline characteristics 

Patients with D-IBS, from September in 2003 to 

May in 2005, visiting Changqiao community hospital 
and Traditional Chinese medical hospital in Putuo 
District in Shanghai, China, were screened. 103 
patients have been included (62 in Changqiao, 41 in 
Putuo, respectively), aged from 19 to 65(MD, 41.3), 
with the durations from 6 months to 30 years(MD, 
7.5), having family history of diarrhea in 37 
cases(35.92%). 

6. Grouping 

Adopting single randomized method, according to 

randomized number chart to make cards and 
envelopes, screened patients were subgrouped 
according to associated randomized number and 
provided treatment. Odd numbers are assigned to 
control group, while even numbers are assigned to 
treatment group. 

 

Treatment Methods 

 

1. Treatment group 

Acupoint: bilateral Tianshu(ST 25). 
Operation: routine disinfection, filiform needle 

pricking 0.5 cun and stimulating by HAN's instrument, 
dense-sparse wave: AM2/100 Hz, impulse width 
0.2-0.6 ms, intensity 2-4 mA. 30 min per treatment, 
once a day, 6 times for one course, one day off 
between two courses, 2 courses in all. 

background image

Journal of Acupuncture and Tuina Science, Volume 5, Number 2, 2007 April 

Copyright©2007 Shanghai Research Institute of Acupuncture and Meridian︱

  93  

 

2. Control group 

Acupoint: Daheng (SP 15), bilateral, routine 

disinfection, filiform needle pricking 0.5 cun and 
stimulating by HAN's instrument, dense-sparse wave: 
AM2/100 Hz, impulse width 0.2-0.6 ms, intensity 2-4 
mA. 30 minutes per treatment, once a day, 6 times for 
one course, one day off between two courses, 2 
courses in all. 

 

Therapeutic Effects Evaluation 

 

1. Observational Items 

Clinical symptoms: including key signs, diarrhea 

(stool frequency of a day, consistency, occurrence in a 
week), abdominal pain(frequency, extent, period), 
abdominal distention or discomfort(frequency, extent, 
duration), and other signs, such as rumbling, sensation 
of incomplete evacuation, sensation of urgency, 
mucous stool, poor appetite, abdominal distention or 
pain, fatigue, psychological abnormity etc. 

Referencing to diagnostic and therapeutic effect 

criteria of gastrointestinal disease for IBS ROME II, and 
therapeutic effect criteria of diarrhea, Zhong Yi Bing 
Zheng Zhen Liao Chang Gui

[9]

, released by State 

Administration of Traditional Chinese Medicine. The 
therapeutic effect criteria have been set up eventually. 

R=(N score before treatment-N score after 

treatment) /N score before treatment×100% 

Cure: normal stool, other symptoms primarily 

relieve R>=90% 

Improvement: frequency reduces remarkably, other 

signs improve, 30%<=R<90%; 

No effect: no improvement of stool frequency, and 

no improvement of other symptoms, R<30%. 

2. Statistical analysis 

According to proportion of symptoms before 

treatment, rank test of two samples for group design 
was adopted, Ridit analysis was also used when 
therapeutic effects of two groups before and after 
treatment were compared.   

 

Results 

 

1. Comparison of clinical data of two groups 

The incidence and proportion of key symptoms for 

D-IBS (Table 1) By analysis, key symptoms of D-IBS, 
such as diarrhea, abdominal pain, sense of urgency 
have incidence of over 80%, which are most familiar 

signs. Distention or discomfort, rumbling, sense of 
incompletion, mucous stool, psychological 
abnormality have incidence of 45% to 80%. While 
poor appetite, gastro discomfort, fatigue have 
incidence of less than 45%. Rank test of two samples 
for group design has been used, but there is no 
significant difference in key symptoms of two 
groups(P>0.05). So the key symptoms of two groups 
could be comparative.   

2. Overall clinical observation 

EA on Tianshu(ST 25) group 11 cases(20.8%) 

cured, improvement 34 cases(64.1%), no effect 8 
cases(15.1%), effective rate in all 84.9%; EA on 
SP-15 4 cases cured(8.0%), improvement 26 
cases(52.0%), no effect 20 cases(40.0%), effective 
rate 60%(Table 2). By chi-square test, a 24.9% of 
significant difference between two groups has been 
detected(P<0.05) with 90% power at the α=0.05 
significance level, which indicates that efficacy of  
EA on ST 25 is superior to one of EA on SP-15. 

Table 1. Comparisons of key symptoms incidence(cases) 

Clinical signs 

ST 25  SP 15  N   Incidence 

(%) 

Diarrhea  

53 

50 

103  100.00% 

Abdominal pain 

49 

43 

92  89.32% 

Distention or discomfort 

36 38 74 

71.84% 

Rumbling  

38 

39 

77  74.76% 

Sense of incompletion 

41 

40 

81  78.64% 

Sense of urgency 

46 

40 

86  83.50% 

Mucous stool 

23 

30 

53  51.46% 

Poor appetite 

19 

15 

34  33.01% 

Gastro discomfort 

22 

24 

46  44.66% 

Fatigue  

21 

22 

43  41.75% 

Psychological abnormality    26 

23 

49  47.57% 

Table 2. Comparison of symptoms in two groups 

Group 

Cure Improvement  No 

effect 

ST 25 

53 

11 

34 

SP-15 50 

4  26 

20 

 

Discussions 

 

To the treatment of IBS, there is no specific method 

or drug. Many IBS patients accept a single treatment, 
and current measures are symptom-oriented, aimed at 
removing inducing factors and correcting the relevant 
pathological or physical changes. Recently, reports at

background image

Journal of Acupuncture and Tuina Science, Volume 5, Number 2, 2007 April 

     

94

      ●

Copyright ©

 

2007 Shanghai Research Institute of Acupuncture and Meridian 

home and abroad have shown that acupuncture 

remedy has satisfactory therapeutic effects, previous 
studies of our research group, from aspects of clinic 
and mechanism, have indicated that acupuncture 
represents potentially valuable therapeutic remedy for 
treatment of IBS

[7-11]

. However, there is no systematic 

research on a single acupoint Tianshu (ST 25), and no 
united quality control criteria, and that will affect the 
clinical application of treating IBS with Tianshu(ST 
25). Therefore, it is greatly necessary in this area.   

Global evaluation of symptoms for D-IBS showed 

the incidence of key symptoms, such as diarrhea, 
abdominal pain, sense of urgency was over 80%, and 
so they are familiar symptoms of D-IBS patients. 
While distention(71.8%), rumbling(74.8%), sense of 
incompletion(78.6%), mucous stool(51.5%), psycho- 
abnormality (47.6%), are common symptoms too with 
an incidence of 45% to 80%. Since psychological 
questionnaires are not involved in this research, 
psycho-abnormality here doesn't refer to psychopathic 
problem. On the contrary, doctors inquires patients' 
psychological stress, personality (whether anxiety, or 
nervousness, or sensitivity to dealing with situation, 
circumstances stress, relationship of stress and 
diarrhea, abdominal pain et al), dealing way, etc. The 
sensitivity of patients is called character of sensitivity. 
Psycho-abnormality, in fact, refers to inclination of 
sensitive personality. This research indicates that 
sensitive rate of IBS is 47.6%, This is a pretty high 
rate, which is in accordance with opinions of many 
scholars.

 [10-12] 

Therefore, IBS is considered as typical 

psychosomatic disease

 [10, 12-13]

.

 

While poor appetite, 

gastric discomfort, fatigue have incidence of less than 
45% (33.0%, 44.7%, and 41.8%). 

In a word, multiple symptoms of D-IBS could be 

improved by EA on Tianshu (ST 25), EA on Tianshu 
(ST 25) is superior to EA on Daheng (SP 15). This 
research proved the description about treatment of 
intestinal problems with Tianshu(ST 25). Tianshu (ST 
25) has a function of "dredging intestine, holding on 
diarrhea, relieving pain", and therapeutic effect of 
Tianshu (ST 25) for treating IBS has been proved. 
From clinical aspect, Tianshu (ST 25), as an acupoint 
of stomach meridian and the front-Mu acupoint of 
Large intestine, is effective and great efficient. So 
Tianshu(ST 25) plays a key role in the treatments of 
IBS. EA on Tianshu (ST 25) to treat IBS should been 

used and popularized. Therefore, this research has 
provided scientific clinical data for the remedy based 
on Tianshu (ST 25).   

 

References 

 

[1] XU Xiao-xing, LI Ding-guo. Distributed Feature of IBS in 

Epidemiology. Chinese Journal of Epidemiology, 2003, 
24(6): 523-525.   

[2] PAN Guo-zong, LU Su-cai, KE Mei-yun, et al. 

Epidemiologic Research of IBS in Beijing: a Group, Layered, 
Random Survey. Chinese Journal of Epidemiology, 2000, 
21(1): 26-29. 

[3] ZHAO Chen, LIU Hui-rong, WU Huan-gan, et al. Literature 

Research of Treating Irritable Bowel Syndrome by 
Acupuncture. Modern Rehabilitation, 2000, 4(4): 616-617. 

[4] CHEN Wen-hua, WU Huan-gan, ZHAO Chen, et al. 

Research on Efficacy and Mechanism by Combination of 
Potential Therapeutic Machine and Acupuncture to Treat 
Irritable Bowel Syndrome.  Modern Rehabilitation, 1999, 
3(6): 647-649. 

[5] WU Huan-gan, WANG Jing-hui, CHEN Han-ping, et al. 

Exploration of Efficacy and Immunological Mechanism for 
Irritable Bowel Syndrome Treated by Moxibustion over 
Herb-partition. Chinese Acupuncture and Moxibustion, 1996, 
16(2): 43-45. 

[6] HUA Xue-gui, WU Huan-gan, CHEN Han-ping. Literature 

Review for Treating Irritable Bowel Syndrome by 
Acupuncture and Massage. Clinical Journal of Acupuncture 
and Moxibustion, 1995, 11(5): 49-51. 

[7] LIU Li-gong, GU Jie. Classical Literature Review of Acute 

Disease Treating by Acupuncture. Shanghai: Shanghai Press 
of Science and Technology, 2000. 

[8] HU Pin-jin. Commitment of Diagnosis and Treatment for 

Irritable Bowel Syndrome. Chinese Journal of Internal 
Medicine, 2003, 42(9): 669-670. 

[9] ZHEN Xiao-yu. Guiding Principle of Clinical Research on 

New Herbs. Beijing: Chinese Publishing House of Medical 
Science and Technology, 2002,139-143. 

[10] WANG Qin, CHEN Lin-qing. Clinical Analysis of Irritable 

Bowel Syndrome and Psychological Abnormality. 
gastroenterology, 2003, 8(supplement): A5. 

[11] Ali A,Toner BB,Stuckless N,et al. Emotional Abuse, 

Self-blame, and Self-silencing in Women with Irritable 
Bowel Syndrome. Psychosom Med,2000 Jan-Feb;62(1):
76-82. 

[12] Gwee KA, Leong YL, Graham C, et al. The Role of 

Psychological and Biological Factors in Post-infective Gut 
Dysfunction.Gut,1999,44(suppl 2): 400-406. 

[13] WANG Wei-an, HE Jian-qin, HU Pin-jin, et al. Influence 

of Psycho-Social Factor on Quality of Life for Irritable 
Bowel Syndrome. World Chinese Journal of Digestology, 
2004, 12(7): 1626-1630. 

 

Received date: January 2, 2007